| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/03/2005 | CN1649889A Process for preparing oligonucleotides |
| 08/03/2005 | CN1649887A Polymer-coated substrates for immobilization of biomolecules and cells |
| 08/03/2005 | CN1649626A Use of molecules which interact with the haptoglobin receptor ligand binding |
| 08/03/2005 | CN1649622A DNA vaccine against proliferating endothelial cells and methods of use thereof |
| 08/03/2005 | CN1649618A Methods |
| 08/03/2005 | CN1649483A ICE1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 08/03/2005 | CN1649482A A method for increasing resistance of monocot plants against abiotic stresses |
| 08/03/2005 | CN1648259A Human protein C expression method and its special primer and expression carrier |
| 08/03/2005 | CN1648256A Method for gradually permeating chromosome small segment to wheat induced by gama-ray and UV |
| 08/03/2005 | CN1648255A Food grade carrier of lactic galactococcus |
| 08/03/2005 | CN1648254A Goose parvo-virus VP1 and VP3 gene non-overlapping sequence pronucleus expression protein and its preparing method |
| 08/03/2005 | CN1648253A Molecule label linked with rice anti-rice blast gene |
| 08/03/2005 | CN1648252A Wheat TaGI1 gene and its cloning and use |
| 08/03/2005 | CN1648251A Human oral scale-like cancer cis-platinum medicine resistant cell cDNA library and preparing method |
| 08/03/2005 | CN1648250A Smal linterference ribonucleic acid sequence of hepatitis B virus gene and preparing method |
| 08/03/2005 | CN1648249A Small molecular interference ribonucleic acid for inhibiting SARS virus gene expression |
| 08/03/2005 | CN1648248A Method for extracting basically pure plasmid by improved alkaline cracking method and multilayer chromatographic device |
| 08/03/2005 | CN1648247A Method for producing recombined blood vessel chalone in bacillus coli and its use |
| 08/03/2005 | CN1648246A Method for transferring Tibetan medicinal effective component into receptor cell using somatic cell cross breeding technology |
| 08/03/2005 | CN1648235A Self floculation hydrogen producing bacteria and its sieving method |
| 08/03/2005 | CN1648135A Transduction peptide-humanized chloine acetylase fusion protein and its use |
| 08/03/2005 | CN1647625A Method for producing new fluorescent fish and new fluorescent fish produced by said method |
| 08/03/2005 | CN1647624A Method for fish gene in site modification breeding |
| 08/03/2005 | CN1213150C Oligonucleotide primer effective with multiple detection of hepatitis C virus (HCV) and human immunologic deficiency virus (HIV) and using method thereof |
| 08/03/2005 | CN1213148C Biodegradable high oxidative stability oils |
| 08/03/2005 | CN1213147C Deoxymugineic acid synthase and gene thereof |
| 08/03/2005 | CN1213146C Process for producing recombinant insulin from novel fused protein |
| 08/03/2005 | CN1213145C Modified EB virus LMP1 coding sequence and its prepn and application |
| 08/03/2005 | CN1213144C Recombination nucleic acid molecule and application thereof |
| 08/03/2005 | CN1213070C Monoclonal antibodies directed against the G3BP protein and use |
| 08/03/2005 | CN1213069C Growth promoting factor and its prepn and use |
| 08/03/2005 | CN1213068C Improvments in or relating to immune responses to HIV |
| 08/03/2005 | CN1213057C Structure of antisense oligonucleotide to inhibit activity of telomerase and its application |
| 08/02/2005 | US6925394 Crystal structure of the 30s ribosome |
| 08/02/2005 | US6924415 Identified as a target for therapeutic intervention due to its role in molecular events that lead to or contribute to cardiac hypertrophy and/or dilated cardiomyopathy |
| 08/02/2005 | US6924414 Muir-torre-like syndrome in Fhit deficient mice |
| 08/02/2005 | US6924412 transgenic, non-human animal with a genome a that has stably integrated, recombinant nucleic acid encoding a polymeric immunoglobulin receptor protein linked to a mammary specific promoter |
| 08/02/2005 | US6924368 Hepatitis B virus (HBV); cDNA encoding said variable region; vectors and transformed cells; use to develop monoclonal antibodies for immunotherapy or diagnosis |
| 08/02/2005 | US6924367 Method of modulating tissue growth using Frzb Protein |
| 08/02/2005 | US6924366 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
| 08/02/2005 | US6924365 Optimized messenger RNA |
| 08/02/2005 | US6924364 Human secreted protein, Zzp1 |
| 08/02/2005 | US6924362 Monoclonal antibodies specific for the E2 glycoprotein of hepatitic C virus and their use in the diagnosis, treatment, and prevention of hepatitis C |
| 08/02/2005 | US6924357 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy |
| 08/02/2005 | US6924356 Human protein HHEPU32 |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6924146 Method of constructing vectors for homologous recombination directed mutagenesis |
| 08/02/2005 | US6924145 transforming plant cells or plant tissue that are sensitive to galactose toxicity with one or more polynucleotide molecule encoding UDP-glucose dependent uridyl transferase |
| 08/02/2005 | US6924144 Method and means for producing high titer, safe, recombinant lentivirus vectors |
| 08/02/2005 | US6924135 DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof |
| 08/02/2005 | US6924131 Protein for use as sweetner in food processing |
| 08/02/2005 | US6924128 Packaging cell lines for generation of high titers of recombinant AAV vectors |
| 08/02/2005 | US6924126 Cloning, expression and characterization of the SPG4 gene responsible for the most frequent form of autosomal spastic paraplegia |
| 08/02/2005 | US6924125 Expression of heterologous multi-domain proteins in yeast |
| 08/02/2005 | US6924123 Transducting, dividing cells; gene expression; gene therapy |
| 08/02/2005 | US6924121 Sperm specific proteins |
| 08/02/2005 | US6924120 sequence linked to a target protein, preferably an insulin precursor; present invention also relates to a process for obtaining a correctly folded insulin-precursor |
| 08/02/2005 | US6924119 cGMP-visualizing probe and a method of detecting and quantifying of cGMP by using the same |
| 08/02/2005 | US6924117 Human RRP sequences and methods of use |
| 08/02/2005 | US6924110 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 08/02/2005 | US6924109 High-throughput transcriptome and functional validation analysis |
| 08/02/2005 | US6924106 Rifamycin biosynthesis gene cluster |
| 08/02/2005 | US6924103 Screening method for gene variation |
| 08/02/2005 | US6924101 Methods for identifying anti-microbial agents |
| 08/02/2005 | US6924100 Nucleotide sequences coding preferential polypeptide for use in the treatment and diagnosis of cardiovascular disorders and headaches |
| 08/02/2005 | US6924098 Nucleic acid ladders |
| 08/02/2005 | US6924097 Plant promoter and method for gene expression using said promoter |
| 08/02/2005 | US6924096 Includes intact stem loop structures and an antisense nucleic acid; useful for inhibition of selected genes in a cell; allele-specific targeting is also useful in combination replacement gene therapy |
| 08/02/2005 | US6924095 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma |
| 08/02/2005 | US6924092 Testing prospective herbicides and parasiticides by incubating a substance with a monogalactodiacyl synthase or plastidal membrane products to select enzyme inhibitors; apicomplex parasites; antimalarial agents; coccidiosis;toxoplasmosis |
| 08/02/2005 | US6923970 Retrovirus-like particles made non-infectious by a plurality of mutations |
| 08/02/2005 | US6923969 Nucleotide sequences coding viral protein for use in vaccinations and veterinary medicine |
| 08/02/2005 | US6923965 comprises inhibitors of glycosaminoglycans; for wound healing and angiogenesis |
| 08/02/2005 | US6923959 Method of pre-inducing a state of immune tolerance before organ transplantation |
| 08/02/2005 | US6923958 For immunizing a mammal against cancer cells that present a carcinoembryonic antigen (CEA) |
| 08/02/2005 | US6923957 Inactivated virulence genes |
| 08/02/2005 | CA2406391C Normalized nucleic acid libraries and methods of production thereof |
| 08/02/2005 | CA2343586C Modified green fluorescent proteins |
| 08/02/2005 | CA2341081C Cloning and expression of microbial phytase |
| 08/02/2005 | CA2168617C Constitutive promoter from tobacco |
| 08/02/2005 | CA2148934C Targetable vector particles |
| 08/02/2005 | CA2135607C Chemical method for the analysis of dna sequences |
| 08/02/2005 | CA2118121C Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 08/02/2005 | CA2078539C Process for producing humanized chimera antibody |
| 07/30/2005 | CA2495497A1 Compositions for eliciting immune response and methods for using same |
| 07/28/2005 | WO2005068662A1 Rapid preparation of nucleic acids by enzymatic digestion |
| 07/28/2005 | WO2005068661A1 Methods and compositions for regulating cell cycle checkpoints |
| 07/28/2005 | WO2005068658A1 Rapid screening method of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom |
| 07/28/2005 | WO2005068646A1 Methods for the protein production and purification of soluble recombinant polypeptides |
| 07/28/2005 | WO2005068643A2 Biochemical synthesis of 6-amino caproic acid |
| 07/28/2005 | WO2005068641A1 Integrase fusion proteins and their use with integrating gene therapy |
| 07/28/2005 | WO2005068639A2 Particle-induced ghrelin immune response |
| 07/28/2005 | WO2005068638A2 Promoter |
| 07/28/2005 | WO2005068637A1 Novel melon plants |
| 07/28/2005 | WO2005068636A1 Ccamk involved in nodulation and endomycorrhization |
| 07/28/2005 | WO2005068634A1 Hiv-1 indian subtype c vaccine constructs for use in humans |
| 07/28/2005 | WO2005068633A1 Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient |
| 07/28/2005 | WO2005068631A1 Ires functioning in plant |
| 07/28/2005 | WO2005068630A1 Double-stranded rna for interference |
| 07/28/2005 | WO2005068629A2 Gene expression inhibition and uses thereof |